Each article is made available under the terms of the . ​All of our articles are available to download individually in PDF format.


Editor’s Pick: Simple, Low-Cost, and Timely Optical Biosensors for the Detection of Epigenetic Biomarkers: The Future of Cancer Diagnosis

Editor’s Pick: Simple, Low-Cost, and Timely Optical Biosensors for the Detection of Epigenetic Biomarkers: The Future of Cancer Diagnosis

October 24, 2017 at 8:29 AM 0 comments

This issue’s Editor’s Pick is a relevant discussion paper from Lechuga et al. on the potential of simple, low-cost, and timely optical biosensors for the detection of epigenetic biomarkers in cancer diagnosis. The development of new methods for the detection and monitoring of cancer has been the subject of intenseRead More

The Janus-Faced Role of Cell-Mediated Immune Responses in Pancreatic Cancer

The Janus-Faced Role of Cell-Mediated Immune Responses in Pancreatic Cancer

October 24, 2017 at 8:28 AM 0 comments

Elena Niccolai,1 Antonio Taddei,1,3 Federica Ricci,2 Maria Novella Ringressi,1,3 *Amedeo Amedei2 1. Department of Surgery and Translational Medicine, University of Florence, Florence, Italy 2. Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy 3. Department of Biomedicine, Azienda Ospedaliera Universitaria Careggi (AOUC), Florence, Italy *Correspondence to aamedei@unifi.it Disclosure:Read More

Post-Surgical Strategies for Prostate Cancer: Clinicopathologic and Genomics Criteria

Post-Surgical Strategies for Prostate Cancer: Clinicopathologic and Genomics Criteria

October 24, 2017 at 8:27 AM 0 comments

Alessandro Morlacco,1 Matteo Soligo,1 Michele Colicchia,2 Avinash Nehra,2 *R. Jeffrey Karnes3 1. Padua University Hospital, Padua, Italy 2. Mayo Clinic, Rochester, Minnesota, USA 3. Urology Department, Mayo Clinic, Rochester, Minnesota, USA *Correspondence to Karnes.R@mayo.edu Disclosure: R. Jeffrey Karnes has received research funding from GenomeDx and is employed by the MayoRead More

Prognostic and Predictive Value of FDG-PET as an Aid in Oesophageal Cancer Management

Prognostic and Predictive Value of FDG-PET as an Aid in Oesophageal Cancer Management

October 24, 2017 at 8:26 AM 0 comments

Mian Xi,1,2 *Steven H. Lin3 1. Department of Radiation Oncology, Cancer Center, Sun Yat-Sen University, State Key Laboratory of Oncology, Guangzhou, China 2. Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China 3. Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA *Correspondence to shlin@mdanderson.orgRead More

Understanding the Microenvironment of Melanoma Cells for the Development of Target Drug Delivery Systems

Understanding the Microenvironment of Melanoma Cells for the Development of Target Drug Delivery Systems

October 24, 2017 at 8:25 AM 0 comments

*Lucas B. Naves,1,2,3 Luis Almeida,2 Seeram Ramakrishna,3,4 1. CAPES Foundation, Ministry of Education of Brazil, Brasília, Brazil 2. Centre for Textile Science and Technology, University of Minho, Guimarães, Portugal 3. Center for Nanofibers & Nanotechnology, Department of Mechanical Engineering, National University of Singapore, Singapore 4. Guangdong-Hong Kong-Macau Institute of CNS RegenerationRead More

Chemotherapy for Extracranial Germ Cell Tumours in Paediatric, Adolescent, and Young Adult Patients

Chemotherapy for Extracranial Germ Cell Tumours in Paediatric, Adolescent, and Young Adult Patients

October 24, 2017 at 8:24 AM 0 comments

*Rong-Long Chen,1 Han-Ting Lin,2 Liuh-Yow Chen3 1. Department of Pediatric Hematology and Oncology, Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan 2. Department of Medical Oncology, Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan 3. Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan *Correspondence to ronglongchen@yahoo.com.tw Disclosure: The authors haveRead More

Malignant Pleural Mesothelioma: Spotlight on Recent Advances in Diagnosis and Treatment

Malignant Pleural Mesothelioma: Spotlight on Recent Advances in Diagnosis and Treatment

October 24, 2017 at 8:23 AM 0 comments

Aline N. Zouk, *Hitesh Batra Division of Pulmonary, Allergy, and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA *Correspondence to hbatra@uabmc.edu Disclosure: The authors have declared no conflicts of interest. Received: 19.06.17 Accepted: 18.09.17 Citation: EMJ Oncol. 2017;5[1]:103-111. Abstract Pleural malignancies constitute either primary pleural malignancies, such asRead More

Editor’s Pick: Renal Involvement in Multiple Myeloma

Editor’s Pick: Renal Involvement in Multiple Myeloma

August 31, 2017 at 8:24 AM 0 comments

Fifteen years ago, renal involvement and renal failure were almost inevitable consequences of multiple myeloma, dramatically impacting survival and quality of life. Since the introduction of innovative drugs (the so called ‘new drugs’ and ‘newer drugs’), autologous haemopoietic cell transplantations, and the innovative technique of light chain removal, myeloma outcomesRead More

A Theoretical View of Ovarian Cancer Relapse

A Theoretical View of Ovarian Cancer Relapse

August 31, 2017 at 8:13 AM 0 comments

*Gonzalo H. Giornelli, Pablo Mandó Genito Urinary Oncology Department, Instituto Alexander Fleming, Buenos Aires, Argentina *Correspondence to gongiorne@yahoo.com.ar Disclosure: The authors have declared no conflicts of interest. Acknowledgements: The authors would like to thank Maria Liuisa Poljak for her assistance in bibliography searching. Received: 27.09.16 Accepted: 17.01.17 Citation: EMJ. 2017;2[3]:128-135.Read More

Recent Developments in Regorafenib Treatment for Gastrointestinal Cancers: Presentations at the 2016 Meeting of the European Society for Medical Oncology (ESMO) Congress 2016

Recent Developments in Regorafenib Treatment for Gastrointestinal Cancers: Presentations at the 2016 Meeting of the European Society for Medical Oncology (ESMO) Congress 2016

December 13, 2016 at 8:26 AM 0 comments

Axel Grothey,1 Gerald Prager,2 *Jean-Yves Blay3 1. Mayo Clinic, Mayo Clinic College of Medicine, Rochester, Minnesota, USA 2. Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University Vienna, Vienna, Austria 3. Centre Léon Bérard, Université Claude Bernard Lyon 1, Lyon, France *Correspondence to jean-yves.blay@lyon.unicancer.fr Disclosure: Prof Jean-Yves Blay hasRead More